TERT
TERT (telomerase reverse transcriptase, also known as TRT, TP2, TCS1, hEST2 and EST2) is the catalytic protein component of telomerase. It extends chromosome ends by copying a template within the telomerase RNA component, adding TTAGGG repeats to telomeres. Browse Assay Genie's current range of TERT research reagents below, or read on for the biology behind the target.
Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. TERT is its catalytic component and acts as a reverse transcriptase: it copies a template sequence within the RNA component of the enzyme to add simple sequence repeats to chromosome ends. It catalyses RNA-dependent extension of 3'-chromosomal termini with the six-nucleotide telomeric repeat 5'-TTAGGG-3'. The catalytic cycle involves primer binding, primer extension, and either release of product once the template boundary is reached or translocation of the nascent product followed by further extension. The enzyme is more active on substrates containing two or three telomeric repeats. Its activity is regulated by telomerase complex-associated proteins, chaperones and polypeptide modifiers.
The TERT gene encodes a member of the reverse transcriptase family, telomerase subfamily, and the protein is classed by HGNC among the telomerase holoenzyme subunits. UniProt records localisation to the nucleus, including the nucleolus, nucleoplasm and PML bodies, as well as to chromosome telomeres and the cytoplasm. Mouse and rat both carry a Tert ortholog. Alternatively spliced variants encoding different isoforms have been identified, and alternative splicing at this locus is thought to be one mechanism for regulating telomerase activity.
TERT is active in progenitor and cancer cells, but inactive or at very low activity in normal somatic cells. Its repression in postnatal somatic cells leads to progressive telomere shortening, linking telomerase expression to cellular senescence, while deregulated expression in somatic cells may be involved in oncogenesis. UniProt also notes that TERT modulates Wnt signalling and has roles in ageing and antiapoptosis. Studies in mouse suggest telomerase participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks.
TERT is the catalytic subunit that adds TTAGGG repeats to chromosome ends, making it central to studies of telomere maintenance.
Telomerase is active in cancer cells, and its deregulation in somatic cells may be involved in oncogenesis.
Repression of TERT in postnatal somatic cells causes progressive telomere shortening, linking it to cellular senescence and ageing.
TERT is active in progenitor cells but not in normal somatic cells, which makes it relevant to proliferative potential.
TERT is the catalytic component of telomerase. It acts as a reverse transcriptase, copying a template within the telomerase RNA to add TTAGGG repeats to the 3' ends of chromosomes. This offsets telomere shortening and supports replication of chromosome termini.
TERT is also known as TRT, TP2, TCS1, hEST2 and EST2, and its full name is telomerase reverse transcriptase. NCBI Gene reports alternatively spliced variants encoding different isoforms, and splicing is thought to be one way telomerase activity is regulated.
Mouse and rat both have a Tert ortholog, and studies in mouse have informed understanding of telomerase function. TERT is normally repressed in somatic cells, and deregulated expression may be involved in oncogenesis. Check the datasheet of any product for its validated reactivity.
Telomerase components, telomere-binding proteins and Wnt signalling markers relevant to TERT research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O14746; product specifications from Assay Genie datasheets.